These findings provide evidence that genetic variations of TF-DNA binding from the pioneer factor FOXA1 and co-factors may control the core transcriptional regulatory circuitry, and confer breast cancer susceptibility. The gene discussed is FOXA1; the disease is breast carcinoma.